G105G SNP carriers showed a similar outcome compared to other IDH-wildtype glioblastoma patients (OS: HR = 0.82, CI = 0.45–1.49, p = 0.55; PFS: HR = 0.69, CI = 0.40–1.21, p = 0.360). Here, IDH2 is linked to glioblastoma.